Back

Tumor-Origin.com: A Machine Learning Platform for Predicting Tumor Tissue of Origin from Somatic Mutation Profiles

2026-01-01 oncology Title + abstract only
View on medRxiv
Show abstract

Standard pathology workup sometimes fails to definitively identify tumor tissue-of-origin in cancers with ambiguous diagnoses or unknown primary sites, complicating treatment decisions. Molecular assays can aid diagnosis but require additional tissue and increase healthcare costs. Intending to leverage routinely collected somatic mutation profiles from comprehensive genomic profiling, we developed Tumor-Origin.com, a machine learning platform to predict tumor tissue-of-origin from mutation data ...

Predicted journal destinations